Do you want to read an article? Please log in or register.
Optimal Treatment Strategies for Pulmonary Large Cell Neuroendocrine Carcinoma Based on Molecular Subtypes
Lung Cancer
RECOMMENDED
Related content
Lung Cancer
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use
Clin Lung Cancer
Joshi U, Ong F, Melzer D, Ma JC, Saltos A, Chiappori A, Creelan B, Pellini B, Lu C, Haura E, Shafique M, Tanvetyanon T, Kareem SS, Budhathoki P, Solarte DCB, Naqvi SMH, Puglianini OC, Gaballa S, Gray JE, Puri S
doi: 10.1016/j.cllc.2025.11.018
Lung Cancer
CAR-T cell therapy for the treatment of lung cancer: Current challenges and emerging therapeutic strategies
Lung Cancer
Shi D, Yan X, Liu J, Chen H, Wang X, Li R, Tian X, Lin X, Wang Y
doi: 10.1016/j.lungcan.2025.108849
Lung Cancer
Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States
Adv Ther
Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S
doi: 10.1007/s12325-025-03408-z
RECOMMENDED
Lung Cancer
What is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (≥ 5 cm) Non-Small Cell Lung Cancer?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Yoo YJ, Song SY, Shin YS, Kim SS
doi: 10.1016/j.cllc.2025.07.018
RECOMMENDED
Pulmonary Hypertension
Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Chest
Szwed P, Kurzyna P, Banaszkiewicz-Cyganik M, Kędzierski P, Łomiak M, Wolański R, Wasilewski M, Florczyk M, Piłka M, Torbicki A, Kurzyna M, Darocha S
doi: 10.1016/j.chest.2025.10.017
RECOMMENDED
Lung Cancer
Optimizing Lymph Node Staging in Non-Small Cell Lung Cancer Surgery: Evidence, Guidelines, and Quality Improvement Strategies
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Magouliotis DE, Androutsopoulou V, Cioffi U, Minervini F, Sicouri N, Xanthopoulos A, Scarci M
doi: 10.3390/jcm15020831
Further Publications
Neoadjuvant chemoimmunotherapy in non-small-cell lung cancer patients: Effects on pulmonary function and incidence of postoperative pulmonary complications-a multicenter real-world study
Eur J Cardiothorac Surg
Zhang J, Feng Y, Dai S, Xu G, Cheng B, Jiang L, Xue LP, Liang W, Tang J
doi: 10.1093/ejcts/ezaf351
Lung Cancer
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)
Lung Cancer
Phillips WJ, Zhan LJ, Chowdhury D, Gill J, Sun A, Rittberg R, Cohen V, Gibson AJW, Yan M, Liwski D, Surapaneni S, D'Amours MF, Yu FPS, Kim Y, Qadeer RA, Dawe DE, Agulnik J, Navani V, Fung AS, Snow S, Kuruvilla S, Ho C, Lok BH, Liu G, Wheatley-Price P, Moore S
doi: 10.1016/j.lungcan.2025.108840
Lung Cancer
Site-specific follow-up strategy for surgically resected patients with NSCLC based on ten-year follow-up data
Lung Cancer
Zhang M, Deng C, Fu F, Li Y, Zhang Y, Chen H
doi: 10.1016/j.lungcan.2025.108451